ENTRADA THERAPEUTICS, INC.

Insiders Entrada Therapeutics, Inc.

Equities

TRDA

US29384C1080

Real-time Estimate Cboe BZX Other stock markets 15:35:02 17/05/2024 BST			5-day change	1st Jan Change
15.26 ^USD	+2.07%		+4.67%	-0.53%

05-16	Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing	MT
05-07	Entrada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Entrada Therapeutics Insider Bought Shares Worth $364,673, According to a Recent SEC Filing	05-16	MT
Entrada Therapeutics Adds President Role to COO Nathan Dowden	01-03	MT
Entrada Therapeutics Adds President Role to COO Nathan Dowden	01-03	MT
Entrada Therapeutics Promotes Nathan J. Dowden to President	01-03	CI
Entrada Therapeutics, Inc. Announces Board Changes	12-06	CI
Entrada Therapeutics, Inc. Appoints Gina Chapman to its Board of Directors, Effective September 1, 2023	10/08/23	CI
Insider Sell: Entrada Therapeutics	12/07/23	MT
Insider Sell: Entrada Therapeutics	12/07/23	MT
Insider Sell: Entrada Therapeutics	22/06/23	MT
Entrada Therapeutics, Inc. Announces Board Changes	08/06/23	CI
Entrada Therapeutics, Inc. Appoints Dr. Bernhardt Zeiher to Its Board of Directors	04/04/23	CI
Insider Sell: Entrada Therapeutics	29/12/22	MT
Insider Sell: Entrada Therapeutics	28/09/22	MT
Insider Sell: Entrada Therapeutics	28/09/22	MT
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer	19/07/22	CI
Insider Sell: Entrada Therapeutics	29/06/22	MT
Insider Buy: Entrada Therapeutics	05/11/21	MT
Insider Buy: Entrada Therapeutics	04/11/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer